Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol-Myers (BMY) to Report Q2 Earnings: What's in Store?
01:08pm, Tuesday, 25'th Jul 2023
Investors are likely to focus on the demand for Eliquis and Opdivo along with an incremental contribution from newer drugs when Bristol-Myers (BMY) reports Q2 results.
2 Cheap High-Yield Dividend Stocks to Buy Now
11:15am, Tuesday, 25'th Jul 2023
Many high-yielding stocks are either too risky or too expensive. Amgen and Bristol Myers Squibb offer above-average dividend yields, attractive valuations, and a reasonable margin of safety.
Bristol-Myers Squibb Is A Buy At Current Support (Technical Analysis)
07:56am, Sunday, 23'rd Jul 2023
Bristol-Myers Squibb Company (BMY) is a promising investment opportunity due to its strong presence in oncology and immunology, and its robust pipeline of compounds in development. The stock price of
Bristol Myers Squibb: The Gift Has Arrived
01:07am, Sunday, 23'rd Jul 2023
Bristol-Myers Squibb is expected to report its Q2 results on July 27, with market sentiments highly pessimistic, heading into its earnings release. The company faces revenue challenges due to the loss
The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023
03:31pm, Friday, 21'st Jul 2023
Pharma stocks experienced an abysmal first half due to various factors. Rotation from defensive to cyclical sectors, drug price negotiations and upcoming patent cliffs have muddied the outlook.
Bristol Myers Squibb (BMY) Earnings Expected to Grow: Should You Buy?
11:26am, Thursday, 20'th Jul 2023
Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bristol-Myers: Potentially Set To Soar And Too Cheap To Ignore
07:20am, Wednesday, 19'th Jul 2023
Greed has gripped the market, but that doesn't mean you can't invest wisely. Even today, anti-bubble blue-chip bargains like Bristol-Myers Squibb Company are hitting new 52-week lows. Bristol-Myers is
Final Trade: BMY, DHI, ITB, ETHE
06:13pm, Friday, 14'th Jul 2023
The final trades of the day with the Fast Money traders.
Bristol Myers Squibb (BMY) Flat As Market Gains: What You Should Know
07:22pm, Thursday, 13'th Jul 2023
Bristol Myers Squibb (BMY) closed at $62.28 in the latest trading session, marking no change from the prior day.
Big Pharma Ramps Up Fight Against Medicare Price Negotiations
11:50am, Thursday, 13'th Jul 2023
The U.S. Chamber of Commerce asked a judge to stop the federal government from putting into effect a law that will allow Medicare to negotiate the prices of some prescription drugs.
3 Dividend Stocks Poised To Outperform The Rest Of 2023
09:15am, Thursday, 13'th Jul 2023
The S&P 500 and Nasdaq saw a significant rally in the first half of 2023, led by technology companies, with the top three performing sectors being Information Technology, Communication Services, and C
Bristol Myers' bladder cancer drug meets goal in late stage sub-study
07:19am, Tuesday, 11'th Jul 2023
Bristol-Myers Squibb Co said on Tuesday its drug in combination with chemotherapy met a dual main goal in a late-stage trial in patients with a type of bladder cancer.
Bristol Myers Squibb Is A Buy At Current Valuation
11:50am, Friday, 07'th Jul 2023
Bristol Myers Squibb is an attractive investment due to its consistent growth in sales and earnings per share, along with a generous dividend and aggressive buybacks. Despite facing challenges such as
EVT: Earn Needed Income With This High-Yielding CEF
06:04pm, Thursday, 06'th Jul 2023
EVT: Earn Needed Income With This High-Yielding CEF
Which Stock Is A Better Healthcare Pick – Bristol Myers Squibb Or HCA?
09:00am, Thursday, 06'th Jul 2023
There is more to the comparison, and in the sections below, we discuss why we believe BMY stock will offer higher returns than HCA stock in the next three years.
